These pathways require the transcriptional activity of hypoxia-inducible factor 1 (HIF-1) which acts as a “crucial switch” promoting glycolysis and neoangiogenesis11, oncogene signaling, and a host of metabolic, survival, and proliferative effects necessary for brain tumor growth12,13. The gene discussed is HIF1A; the disease is brain neoplasm.